Skip to content

Provider profile

Pharmaron.

Bioanalytical services

Pharmaron describes bioanalytical services: method development, validation and sample analysis, PK, immunogenicity, biomarker, cell-based, flow cytometry and PCR/ddPCR assays on LC-MS/MS and ligand-binding platforms, for small molecules, peptides, oligonucleotides, proteins, antibodies, ADCs and cell and gene therapies, discovery to clinical. It lists bioanalysis labs in China, the US (Germantown), the UK and Japan.

Website
pharmaron.com (opens in a new tab)
Sources reviewed
November 3, 2026 · Source pages re-checked within 4 months
First published
November 3, 2026

This profile summarizes what public sources state about the provider, mostly its own website. It is not an audit, qualification or endorsement by ArgusBio. Confirm capabilities directly with the provider before contracting.

Services and capabilities

Services and capabilities

  • Biomarker assays2
  • Cell-based assays3
  • Flow cytometry1,2
  • Immunogenicity (ADA/NAb)2
  • Method development1,2
  • Method validation5
  • Molecular assays (qPCR/ddPCR)2,4
  • PK/TK bioanalysis2,3
  • Regulated study-sample analysis1,2

Platforms and methods

  • LC-MS/MS2,5
  • Ligand-binding assays1,2

Sample types

  • Cerebrospinal fluid4Stated for CGT bioanalysis
  • Plasma and serum2
  • Tissue2
  • Urine5
  • Whole blood5Listed as 'blood' for clinical small-molecule bioanalysis

Development experience

Development experience

Development stage

  • Preclinical2

Modality

  • Antibody-drug conjugates2
  • Cell therapies4
  • Gene therapies2
  • Monoclonal antibodies2
  • Oligonucleotides2
  • Peptides2
  • Recombinant proteins2
  • Small molecules2
  • Vaccines2

Locations

Locations

  • Beijing, China · Headquarters7
  • China · Laboratory2
  • Japan · Laboratory2
  • United Kingdom · Laboratory2
  • Germantown, United States · Laboratory7Listed by the company as its 'Clinical Bioanalytical' site

Quality and regulatory

Quality and regulatory

The provider’s own materials state that it works to, or holds, the following. ArgusBio has not inspected or audited these claims.

  • CLIA2Stated for biomarker testing
  • GCLP2Stated for the bioanalysis service unit; sites not specified
  • GCP1,6
  • GLP1,2,6
  • GMP / cGMP2Stated as a certification of the bioanalysis service unit; sites not specified

Unknowns and questions to ask

Unknowns and questions to ask

Public sources rarely establish what matters most for a specific project. Confirm directly:

  • Whether a validated method already exists for your molecule or a close analogue, and who owns it
  • Validation scope against ICH M10 for your assay type, and expected timeline
  • Current instrument and analyst capacity, and turnaround per sample batch
  • Sample receipt, storage conditions, chain of custody and international shipping experience
  • Most recent regulatory inspection or audit outcomes relevant to your studies
  • Data-integrity controls and the format of data delivered to your PK or biometrics vendor

How to select a bioanalytical laboratory

Evidence and sources

Evidence and sources

  1. 1Biomarker Assays | Discovery, Preclinical & Clinical Studies (opens in a new tab)Pharmaron · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
  2. 2Bioanalysis Testing Services I Pharmaron CRO Solutions (opens in a new tab)Pharmaron · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
  3. 3Clinical Bioanalysis Of Large Molecules | Pharmaron (opens in a new tab)Pharmaron · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
  4. 4CGT Bioanalysis For Gene And Cell Therapy | Pharmaron (opens in a new tab)Pharmaron · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
  5. 5Clinical Bioanalysis Of Small Molecules | Pharmaron (opens in a new tab)Pharmaron · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
  6. 6Integrated In Vitro And In Vivo ADME | Pharmaron (opens in a new tab)Pharmaron · Provider website · retrieved November 3, 2026 · last checked November 3, 2026
  7. 7Our Global Site Locations | Pharmaron (opens in a new tab)Pharmaron · Provider website · retrieved November 3, 2026 · last checked November 3, 2026

“Last checked” means we confirmed the page was still available and still contained the cited statement. It does not mean ArgusBio verified the provider or its capabilities.

Something out of date or wrong? Request a correction. Corrections are reviewed against public sources before publication.

Contact

Contact

Contact the provider directly through its public contact page (opens in a new tab). ArgusBio does not forward inquiries to providers and does not receive referral fees.

Compare with other bioanalytical services providers

ArgusBio sourcing

Need help evaluating this provider or comparing alternatives.

Discuss your sourcing need with ArgusBio. We can help define the scope, identify comparable alternatives and organize proposals so the decision stays yours.

Discuss a sourcing need

We work for the biotech, not the vendor. Vendors do not pay for inclusion or placement.